IP Library › Assignment 033694/0165
Patent Assignment
Reel/Frame 033694/0165

Lien

Recorded: 2014-09-05 Pages: 5
Assignor
NABRIVA THERAPEUTICS AG
Executed: 2014-07-16
Assignee
KREOS CAPITAL IV (UK) LIMITED
25-28 OLD BURLINGTON STREET, LONDON, W1S 2AN, UNITED KINGDOM
Covered Properties (2)
Organic Compounds
Patent: 8,222,447 →
Application: 13/061,692 →
Publication: US 2011/0184022
Substituted Clavulanic Acid
Patent: 9,120,808 →
Application: 13/395,606 →
Publication: US 2012/0232047
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 11, 2011
From: MANG, ROSEMARIE; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 026105/0458 →
Assignment of Assignor's Interest May 25, 2012
From: BULUSU, ATCHYUTA RAMA CHANDRA MURTY
To: NABRIVA THERAPEUTICS AG
Reel/Frame 028275/0729 →
Release of Security Interest Nov 24, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037134/0479 →
Intellectual Property Security Agreement Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest. Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Nunc Pro Tunc Assignment Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →